Physician profile
Sandra C Kim
NPI 1942380043
$1,476.05
in general payments reported to CMS, 2019-2025
9 companies · $903 in 2025
The $903 reported for 2025 was more than what 81% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2021: $122 · 2022: $31.38 · 2023: $98.77 · 2024: $216 · 2025: $903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $821 · Travel and Lodging: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.63 |
| Travel and Lodging | $397.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $397.54 | 2025 | |
| Abbvie INC. | $297.10 | 2019-2025 | |
| Janssen Biotech, INC. | $249.28 | 2024-2025 | Tremfya |
| Celltrion, INC. | $150.00 | 2025 | |
| Fresenius Kabi USA, LLC | $129.53 | 2025 | |
| Boston Scientific Corporation | $122.45 | 2021 | |
| Abbott Laboratories | $57.63 | 2022-2023 | Ensite Precision |
| Samsung Hme America, INC. | $50.00 | 2023 | |
| Evoendo, INC | $22.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.